Rest of World — Net Sales
Edwards Lifesciences Rest of World — Net Sales increased by 7.4% to $177.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.4%, from $150.20M to $177.80M. Over 4 years (FY 2021 to FY 2025), Rest of World — Net Sales shows an upward trend with a 5.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market penetration and growing demand in emerging or secondary international territories, while a decrease may signal competitive pressure or regulatory hurdles in those regions.
Detailed definition
This metric represents the total revenue generated from product sales and services within geographic regions outside of...
Peer comparison
Comparable to 'International Revenue' or 'Emerging Markets Revenue' reported by other global medical device manufacturers.
ew_segment_rest_of_world_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $133.00M | $136.10M | $139.60M | $142.30M | $145.90M | $160.90M | $161.60M | $165.60M | $182.20M | $181.20M | $187.90M | $182.00M | $150.70M | $153.20M | $86.10M | $150.20M | $169.00M | $167.60M | $165.50M | $177.80M |
| QoQ Change | — | +2.3% | +2.6% | +1.9% | +2.5% | +10.3% | +0.4% | +2.5% | +10.0% | -0.5% | +3.7% | -3.1% | -17.2% | +1.7% | -43.8% | +74.4% | +12.5% | -0.8% | -1.3% | +7.4% |
| YoY Change | — | — | — | — | +9.7% | +18.2% | +15.8% | +16.4% | +24.9% | +12.6% | +16.3% | +9.9% | -17.3% | -15.5% | -54.2% | -17.5% | +12.1% | +9.4% | +92.2% | +18.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's rest of world — net sales?
- Edwards Lifesciences (EW) reported rest of world — net sales of $177.80M in Q1 2026.
- How has Edwards Lifesciences's rest of world — net sales changed year-over-year?
- Edwards Lifesciences's rest of world — net sales increased by 18.4% year-over-year, from $150.20M to $177.80M.
- What is the long-term trend for Edwards Lifesciences's rest of world — net sales?
- Over 4 years (2021 to 2025), Edwards Lifesciences's rest of world — net sales has grown at a 5.2% compound annual growth rate (CAGR), from $533.20M to $652.30M.
- What does rest of world — net sales mean?
- Total revenue generated from geographic regions outside of the company's primary established markets.